FDA inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd.: FDA inspection ending Jan 19, 2024
FDA inspection 1233962 · No Action Indicated (NAI) · Lianyungang
Key facts
| Inspection ID | 1233962 |
|---|---|
| Firm | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| FEI number | 3011603969 |
| Address | 1288 Haike Road |
| City | Lianyungang |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Jan 19, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data